domingo, 1 de octubre de 2023

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study Sutanto et al. Oct 2023 Volume 23Number 10p1095-1206, e390-e454 Can we control dengue? The Lancet Infectious Diseases Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study Open Access Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK) Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial Open Access Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

No hay comentarios: